Low-cost detection test for cancer

December 15, 2023

Worldwide each year, 19.3 million people are diagnosed with cancer and the numbers are growing. Nearly 1 in 6 deaths is caused by cancer. The need to expedite diagnostics is vital. As more and curative treatments options are available the earlier cancer is diagnosed and the negative impact on quality of life is reduced. We are in need of a multi cancer test and OncoInv offers you one.

OncoSeek® is a low-cost detection test for cancer

OncoSeek® uses a combination of a selected number of specific plasma tumor markers, a new multivariate algorithm, big data and Machine Learning. It performs screening for the most common cancers, calculates the cancer risk score (CRS), and traces the cancer tissue of origin (TOO). It’s scientifically validated and CE-certified. OncoSeek can be easily implemented as it uses existing medical infrastructure.

OncoSeek® can be used anywhere in the world by medical organisations who provide health services to the public. Laboratory services are included when needed.

If your organisation is interested in OncoSeek® we invite you to contact us at info@oncoinv.org

More news

Nigeria’s Ministery of Health champions early cancer detection through strategic innovation

July 1st, 2025

The Nigerian Ministry of Health is taking decisive steps to address the urgent need for early cancer detection across the country. “It is time for Nigeria to fully embrace the power of early detection. This is not a luxury—it is a necessity in our battle against cancer,” stated Dr. Iziaq Kunle Salako, Minister of Health and Social Welfare...

Read more
Accelerating early cancer detection in Latin America: Biotecgen enters strategic partnership with OncoInv

June 10th, 2025

Biotecgen (Colombia) and OncoInv (The Netherlands) have joined forces to make multi-cancer early detection accessible in Colombia. Biotecgen will offer OncoSeek®, a patient-friendly solution for cancer detection, requiring only a blood sample to detect 9 types of cancer...

Read more
Longevity Medical Institute launches advanced cancer early detection program in Mexico using oncoseek test

April 7th, 2025

Longevity Medical Institute™ (LMI), a leading centre for regenerative medicine and diagnostics in Mexico, has partnered with OncoInv to incorporate the OncoSeek® test into one of the most advanced and accessible cancer detection programs in Latin America...

Read more